MENU
CADL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Candel Therapeutics (CADL) Earnings Date & Reports

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer... Show more

A.I. Advisor
published Earnings

CADL is expected to report earnings to rise 84.78% to -16 cents per share on November 06

Candel Therapeutics CADL Stock Earnings Reports
Q3'25
Est.
$-0.17
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.50
Q4'24
Missed
by $0.10
Q4'23
Missed
by $0.20
The last earnings report on August 14 showed earnings per share of -9 cents, beating the estimate of -15 cents. With 681.71K shares outstanding, the current market capitalization sits at 326.63M.
View a ticker or compare two or three
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CADL showed earnings on August 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
117 Kendrick Street
Phone
+1 617 916-5445
Employees
42
Web
https://www.candeltx.com